Apple is entering the realm of brain-computer interfaces (BCIs) by collaborating with Synchron to enable users to control devices like iPhones, iPads, and the Vision Pro headset using neural signals. This initiative aims to enhance accessibility for individuals with severe mobility impairments, such as those caused by ALS or spinal cord injuries.
Apple’s Brain-Computer Interface: A New Era of Accessibility
Apple is developing support for brain-computer interface (BCI) technology that could allow users to control iPhones and other devices using neural signals. Partnering with BCI company Synchron, Apple aims to make its products more accessible for individuals with severe mobility impairments caused by conditions like ALS or spinal injuries.
How the Technology Works
Synchron’s Stentrode device, implanted in a vein near the brain’s motor cortex, reads brain signals and converts them into device commands using Apple’s Switch Control feature. Early test user Mark Jackson, who has ALS, is already using the technology to control an iPhone, iPad, and Apple Vision Pro headset. Although navigation is slower than typical interactions, the technology shows promise.
Apple’s Commitment to Accessibility
Apple has unveiled a series of significant accessibility updates across its platforms to aid users with diverse needs. A key new feature is the introduction of Accessibility Nutrition Labels in the App Store, helping users quickly identify which accessibility features an app supports. Apple is also collaborating with brain-computer interface company Synchron to introduce Switch Control for BCIs, potentially enabling users to interact with devices using brain signals via implants like the Stentrode.
Future Prospects
Apple plans to release a software standard for developers by the end of the year. The eventual goal is full BCI access for a broader audience once regulatory approval is secured. Analysts estimate up to 150,000 Americans could benefit from BCIs by 2030, with commercial approval anticipated within the next five years.
Comparison with Neuralink
Elon Musk’s Neuralink, a competitor, has an implant (N1) that captures more detailed brain data with over 1,000 electrodes versus Synchron’s 16, showing faster cursor movement. Neuralink’s device, called the N1, captures much more brain data than Synchron’s because it has more than 1,000 electrodes picking up neural activity compared with the Stentrode’s 16. Also, the N1’s electrodes are implanted inside the brain rather than … The neural data picked up by its … .
Conclusion
Apple’s foray into brain-computer interfaces marks a significant step toward enhancing accessibility for individuals with severe mobility impairments. By collaborating with Synchron and developing support for BCIs across its platforms, Apple is paving the way for more inclusive technology that empowers users to interact with their devices in new and innovative ways.The Times of India
